Immunovant, Inc. Quarterly Operating Lease, Payments in USD from Q2 2020 to Q1 2021
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Immunovant, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q2 2020 to Q1 2021.
- Immunovant, Inc. Operating Lease, Payments for the quarter ending March 31, 2021 was $200K.
- Immunovant, Inc. Operating Lease, Payments for the twelve months ending March 31, 2021 was $900K.
- Immunovant, Inc. annual Operating Lease, Payments for 2023 was $1.2M, unchanged from 2022.
- Immunovant, Inc. annual Operating Lease, Payments for 2022 was $1.2M, unchanged from 2021.
- Immunovant, Inc. annual Operating Lease, Payments for 2021 was $1.2M, a 33.3% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)